These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 19726155

  • 1. Results of liver resection in combination with radiofrequency ablation for hepatic malignancies.
    Eisele RM, Zhukowa J, Chopra S, Schmidt SC, Neumann U, Pratschke J, Schumacher G.
    Eur J Surg Oncol; 2010 Mar; 36(3):269-74. PubMed ID: 19726155
    [Abstract] [Full Text] [Related]

  • 2. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H, Kagoshima Liver Cancer Study Group.
    J Hepatobiliary Pancreat Surg; 2009 Mar; 16(3):359-66. PubMed ID: 19300896
    [Abstract] [Full Text] [Related]

  • 3. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
    Tepel J, Hinz S, Klomp HJ, Kapischke M, Kremer B.
    Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
    [Abstract] [Full Text] [Related]

  • 4. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJ.
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].
    Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH, Hwang YJ, Kim YI.
    Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886
    [Abstract] [Full Text] [Related]

  • 7. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
    Hoffman AL, Wu SS, Obaid AK, French SW, Lois J, McMonigle M, Ramos HC, Sher LS, Lopez RR.
    Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
    [Abstract] [Full Text] [Related]

  • 8. Treatment of stage IVA hepatocellular carcinoma: should we reappraise the role of surgery?
    Chirica M, Scatton O, Massault PP, Aloia T, Randone B, Dousset B, Legmann P, Soubrane O.
    Arch Surg; 2008 Jun; 143(6):538-43; discussion 543. PubMed ID: 18559745
    [Abstract] [Full Text] [Related]

  • 9. Experience with more than 500 minimally invasive hepatic procedures.
    Buell JF, Thomas MT, Rudich S, Marvin M, Nagubandi R, Ravindra KV, Brock G, McMasters KM.
    Ann Surg; 2008 Sep; 248(3):475-86. PubMed ID: 18791368
    [Abstract] [Full Text] [Related]

  • 10. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
    Raut CP, Izzo F, Marra P, Ellis LM, Vauthey JN, Cremona F, Vallone P, Mastro A, Fornage BD, Curley SA.
    Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731
    [Abstract] [Full Text] [Related]

  • 11. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
    Kawano Y, Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, Shibata K, Ohta M, Kitano S.
    Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
    [Abstract] [Full Text] [Related]

  • 12. Solitary colorectal liver metastasis: resection determines outcome.
    Aloia TA, Vauthey JN, Loyer EM, Ribero D, Pawlik TM, Wei SH, Curley SA, Zorzi D, Abdalla EK.
    Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
    [Abstract] [Full Text] [Related]

  • 13. [Transdiaphragmatic radiofrequency ablation of malignant liver tumors].
    Takeda Y, Hasuike Y, Kashiwazaki M, Shin E, Tsujinaka T.
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2229-33. PubMed ID: 12484043
    [Abstract] [Full Text] [Related]

  • 14. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A.
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term outcomes after hepatic resection combined with radiofrequency ablation for initially unresectable multiple and bilobar liver malignancies.
    Qiu J, Chen S, Wu H.
    J Surg Res; 2014 May 01; 188(1):14-20. PubMed ID: 24387841
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
    Cheung TT, Ng KK, Poon RT, Fan ST.
    J Hepatobiliary Pancreat Surg; 2009 May 01; 16(5):655-60. PubMed ID: 19370304
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.